Tailored Solutions for GLP-1 RA Research for GLP-1 RA Research Whether you're studying weight loss efficacy, glycemic control, cardiovascular outcomes, or quality of life improvements, Signant Health's ePRO solutions deliver: Robust data collection for primary and secondary endpoints Expert input from our team of 50+ clinicians and COA scientists to drive highest quality evidence generation Evidence generation to support for health technology assessments and economic evaluations 24/7 global patient and site support Seamless integration of decentralized trial elements, such as eConsent, TeleVisits, and more
Approximately 90% of people with diabetes have type 2 diabetes, and the vast majority of these will die of CAD
Common misconceptions about tirzepatide and autoimmune disease The growing interest in tirzepatide for autoimmune conditions has unfortunately generated misconceptions that deserve direct correction
[2] When to seek urgent advice: Contact your GP or healthcare provider promptly if you: Suspect you may be pregnant whilst taking GLP-1 medication Experience sudden changes in menstrual patterns Develop severe abdominal pain (especially if radiating to the back), persistent vomiting, or signs of gallbladder problems Experience severe, persistent vomiting or diarrhoea leading to dehydration Your healthcare team can coordinate care between endocrinology, gynaecology, and fertility services as needed, ensuring that your weight management and reproductive health goals are addressed safely and effectively
Symptoms of B12 deficiency can take decades to develop, and can usually only be diagnosed by a medical professional